Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS)
CNY 7.82
(0.13%)
CNY 7.82
(0.13%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 339.62 Million CNY | 17.61% |
| 2022 | 296.88 Million CNY | 59.4% |
| 2021 | 191.29 Million CNY | 47.42% |
| 2020 | 122.52 Million CNY | 35.09% |
| 2019 | 86.04 Million CNY | 30.24% |
| 2018 | 71.23 Million CNY | -15.72% |
| 2017 | 80.14 Million CNY | 6.1% |
| 2016 | 83.51 Million CNY | -12.97% |
| 2015 | 86.07 Million CNY | 97.41% |
| 2014 | 43.4 Million CNY | 39.25% |
| 2013 | 32.49 Million CNY | 226.9% |
| 2012 | 8.95 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 80.54 Million CNY | -27.83% |
| 2024 Q1 | 139.48 Million CNY | 180.25% |
| 2024 Q3 | 55.68 Million CNY | -41.43% |
| 2023 Q2 | 76.53 Million CNY | -33.91% |
| 2023 Q3 | 78.25 Million CNY | 2.24% |
| 2023 FY | - CNY | 17.61% |
| 2023 Q1 | 115.79 Million CNY | 115.31% |
| 2023 Q4 | 38.56 Million CNY | -50.72% |
| 2022 Q4 | 53.78 Million CNY | -13.46% |
| 2022 Q2 | 61.75 Million CNY | -27.54% |
| 2022 Q1 | 85.21 Million CNY | 145.92% |
| 2022 FY | - CNY | 59.4% |
| 2022 Q3 | 62.14 Million CNY | 0.64% |
| 2021 Q2 | 42.92 Million CNY | -11.67% |
| 2021 FY | - CNY | 47.42% |
| 2021 Q1 | 48.59 Million CNY | 112.22% |
| 2021 Q4 | 34.65 Million CNY | 14.12% |
| 2021 Q3 | 30.36 Million CNY | -29.26% |
| 2020 Q3 | 18.51 Million CNY | -49.87% |
| 2020 Q2 | 36.93 Million CNY | 62.19% |
| 2020 FY | - CNY | 35.09% |
| 2020 Q1 | 22.77 Million CNY | 83.46% |
| 2020 Q4 | 22.89 Million CNY | 23.67% |
| 2019 Q3 | 21.33 Million CNY | -21.57% |
| 2019 Q2 | 27.2 Million CNY | 172.1% |
| 2019 Q1 | 9.99 Million CNY | -50.04% |
| 2019 FY | - CNY | 30.24% |
| 2019 Q4 | 12.41 Million CNY | -41.82% |
| 2018 Q1 | 10.73 Million CNY | -54.18% |
| 2018 Q3 | 6.26 Million CNY | -58.96% |
| 2018 Q2 | 15.27 Million CNY | 42.32% |
| 2018 FY | - CNY | -15.72% |
| 2018 Q4 | 20.01 Million CNY | 219.34% |
| 2017 FY | - CNY | 6.1% |
| 2017 Q3 | 11.66 Million CNY | -37.71% |
| 2017 Q2 | 18.72 Million CNY | 69.85% |
| 2017 Q1 | 11.02 Million CNY | -66.5% |
| 2017 Q4 | 23.41 Million CNY | 100.76% |
| 2016 Q1 | 14.5 Million CNY | 0.0% |
| 2016 Q3 | 8.95 Million CNY | 0.03% |
| 2016 Q2 | 8.94 Million CNY | -38.28% |
| 2016 Q4 | 32.9 Million CNY | 267.62% |
| 2016 FY | - CNY | -12.97% |
| 2015 FY | - CNY | 97.41% |
| 2015 Q1 | 14.42 Million CNY | 0.0% |
| 2014 FY | - CNY | 39.25% |
| 2013 FY | - CNY | 226.9% |
| 2012 FY | - CNY | 0.0% |